Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
作者信息
Eichenauer Dennis A, Bühnen Ina, Plütschow Annette, Kobe Carsten, Dietlein Markus, Wendtner Clemens-Martin, Thorspecken Sven, Topp Max S, Mauser Mareike, von Tresckow Bastian, Fuchs Michael, Borchmann Peter, Engert Andreas
机构信息
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
出版信息
Hematol Oncol. 2022 Oct;40(4):801-804. doi: 10.1002/hon.2986. Epub 2022 Mar 24.
DOI:10.1002/hon.2986
PMID:35313381
Abstract
摘要
Zotero 插件